about
Major Depressive Disorder Predicts Completion, Adherence, and Outcomes in Cardiac RehabilitationBenzodiazepine Use and DrivingPharmacological interventions for apathy in Alzheimer's diseaseLatrepirdine for Alzheimer's diseaseDimebon for Alzheimer's diseaseSedative hypnotics in older people with insomnia: meta-analysis of risks and benefitsDepression rating scales for detection of major depression in people with dementiaA meta-analysis of lipid peroxidation markers in major depressionNeuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureCognitive Outcomes following Transcatheter Aortic Valve Implantation: A Systematic ReviewPotential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinicIndoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery diseaseInterleukin-17 in post-stroke neurodegenerationA meta-analysis of cytokines in Alzheimer's diseaseA positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer diseaseSystematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia.Thrombotic thrombocytopenic purpura associated with clopidogrel: further evaluation.Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment.Do atypical antipsychotics cause stroke?Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery diseasePharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?Effects of ω-3 fatty acids on cognitive performance: a meta-analysis.Current and emerging drug treatment options for Alzheimer's disease: a systematic review.Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis.Kynurenine and depressive symptoms in a poststroke population.Atypical antipsychotics and risk of cerebrovascular accidents.Potential roles of zinc in the pathophysiology and treatment of major depressive disorder.Zinc in depression: a meta-analysis.Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial.Therapy for Alzheimer's Disease: How Effective are Current Treatments?The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis.The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis.Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis.Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study.Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment.A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study
P50
Q22305457-E43FDD82-4962-4752-B69B-7E5A5C62AD6FQ22305460-DCD41082-F1F0-4A14-91C5-1498A3A24263Q24185815-CEA4781E-A0A6-4A9E-AEE6-18758E6C6C19Q24186444-9599BF42-433A-4B08-B278-28685F7C8BB2Q24234998-E07B8353-CE64-497C-87E4-ACA455EF666FQ24538295-F573D6A7-7E2F-40E9-BE23-A7FE346D2B8DQ26470556-B3C1A75B-6254-400B-943C-8B332E0FCC35Q26778489-55E5CCAC-F687-4CF6-AC31-079EB70A56E5Q26864905-EA3F9370-EC65-4B18-9E82-8DA2082FEE84Q27001575-EAAF0E45-CB81-4BD6-AB9F-B64517324B8AQ28194196-3F3B8192-85E9-4847-8C91-201CAEFAF1E2Q28249186-DEA0F1F7-38F8-4041-83B1-A1DBC4B3FF8FQ28284665-F2FE7364-EC2A-4850-A88F-1939C7099433Q28289922-618834FB-B1FF-422E-A29F-F0F850935CB4Q28306131-983FB692-BE3E-45E0-9BCD-C6242E1E2855Q30575371-62F353E8-EEC9-47AA-98E7-4A65BF37A558Q33343620-5DE54AEE-7976-40BA-9CF4-D181AB596B12Q33787909-09447A06-5BC7-4687-9FC7-1702EB7D693CQ33984910-5594A879-5671-44D6-81FA-FFDA363658E7Q34122935-BC6F7D11-B7B9-4E2B-B01A-10C8B0F05B61Q34146983-6AD3487E-79FC-44D1-A035-B785F5EB44A2Q34150618-6470A0D3-297C-4FAF-B815-B7122E3A2284Q34222721-376601D9-988F-4547-81A7-FF10277989B3Q34269777-52B6FB50-F5B8-4BE2-83C4-80671B3CF5FDQ34274565-85102CBA-263B-4088-80BA-BFB7DD8628A9Q34323635-41295C1D-5022-4064-AA10-E430382DA65BQ34337912-89C1E7BF-66D0-40B9-A9FF-5F008D363BC0Q34353975-ED913DE0-5570-4C77-AA8E-6CAD1FA5D56EQ34370011-7FCA22DC-1A5C-4786-A3E3-6CDCD2C7908FQ34380997-1871A0DE-95A1-4D88-B35A-09D72BB3602EQ34409349-038E4891-5612-491C-9B72-14EED673850EQ34540937-6A97C184-4D25-42C9-86E5-4957A8FED265Q34556534-24ED82E9-8440-4AA2-A115-E2F4A4FD3AD6Q34628055-EDDFA897-C4E3-40A5-96FC-FF617873F108Q34629649-F351E748-3708-4FB6-812D-DB3242C5F247Q34648742-D043F117-189E-4832-A182-2D729CBCFFC4Q34662653-6985416D-6BDA-469E-ADBB-CFA9ABA35F51Q34884984-34A77E6C-E796-4129-8064-742D9002D2E7Q34992886-D859CE32-FD15-4B77-A11E-A9E836CCB837Q35065194-3211DDE8-4EDA-4CAD-A068-9460A778BAEA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Krista L Lanctôt
@de
Krista L Lanctôt
@en
Krista L Lanctôt
@fr
Krista L. Lanctot
@ast
Krista L. Lanctot
@es
Krista L. Lanctot
@nl
Krista L. Lanctot
@sl
type
label
Krista L Lanctôt
@de
Krista L Lanctôt
@en
Krista L Lanctôt
@fr
Krista L. Lanctot
@ast
Krista L. Lanctot
@es
Krista L. Lanctot
@nl
Krista L. Lanctot
@sl
altLabel
Krista L. Lanctot
@en
prefLabel
Krista L Lanctôt
@de
Krista L Lanctôt
@en
Krista L Lanctôt
@fr
Krista L. Lanctot
@ast
Krista L. Lanctot
@es
Krista L. Lanctot
@nl
Krista L. Lanctot
@sl
P106
P1153
7003916943
P21
P31
P3835
krista-lanctt
P496
0000-0001-7024-6637